Where does Route 92 Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Route 92 Medical, Inc. ranks #6,379 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Route 92 Medical, Inc. hold?

Route 92 Medical, Inc. holds 53 US utility patents granted between 2017 and 2025, spanning 4 technology areas.

What is Route 92 Medical, Inc.'s Innovation Score?

Route 92 Medical, Inc. has an Innovation Score of 45.1 out of 100 (top 24% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Route 92 Medical, Inc. focus on?

Route 92 Medical, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 52 patents, ranking #361 of 7,127 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Route 92 Medical, Inc.'s patent grant rate increasing or decreasing?

Route 92 Medical, Inc.'s recent grant velocity is +311% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Route 92 Medical, Inc.'s patents?

Route 92 Medical, Inc.'s patents average 25.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Route 92 Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Route 92 Medical, Inc.

USPTO PatentsView assignee record - 53 granted patents across 4 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Route ranks #6,379 of 49,997 tracked US assignees by granted-patent volume, with 53 patents across 4 technology areas.

#6,379
of 49,997 US assignees by volume: Top 24%
by Innovation Score (45.1/100): 25.4
avg claims per patent: +311%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6379 · US Corporation #6,379 · 53 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 53 grants
UPPER-Q #6,379/49,997
PHOTO-FINISH Purity (Xiamen)…
CPC-NARROW A61B · 4 areas
INNOV-PAR 45.1/100
CLAIMS-DENSE 25.4 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +311% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Purity (Xiamen) Sanitary Ware Co., Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Route’s 45.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.8 pts (31%) Velocity 9.3 pts (21%) Breadth 7.1 pts (16%) Claim depth 15.0 pts (33%)

Qualcomm Incorporated · highest

85
Lixil · near

45
Refractory Intellect… · near

45
Route 92 Medical · this assignee

45
Universal Scientific… · near

45
Yamada Manufacturing · near

45
3D Lighting… · lowest

7

What this shows Route's Innovation Score is 45.1/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Route?

Each dot is one of Route’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Route’s own 25.4 claims/patent is ABOVE the 13.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Route vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Route's grants concentrate

Route 92 Medical, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 98.1% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (11 grants) versus a trough of 3 in 2017. By volume, Route sits between Purity (Xiamen) Sanitary Ware Co., Ltd and Sumo Logic, Inc..

Route's three-year grant acceleration

Route 92 Medical, Inc. shows 25 grants in 2022–2024 against only 18 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Purity (Xiamen) S…

53
Qromis

53
R Stahl Schaltger…

53
Revolution Display

53
Ruckus Wireless

53
Shenzhen Yinglaif…

53
Silicon Graphics…

53
Sumo Logic

53
Route 92 Medical ◀

53

What this shows Route holds 53 patents at rank #6,377, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Route

By rank, the assignees closest to #6,377 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Route's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Route, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Route ranks #361 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Universal Scientific Industrial (Shanghai) Co., Ltd. 45 Refractory Intellectual Property GMBH & Co. KG 45 Lixil Corporation 45 Yamada Manufacturing Co., Ltd. 45

Similar claim depth

Nearest assignees by average claims per patent (25.4 here).

Radian Memory Systems, Illc 25.3 avg Enovix Corporation 25.3 avg Mattersight Corporation 25.4 avg Hyperfine Research, Inc. 25.3 avg

Route's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Route 92 Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	3	5.7%
2019	6	11.3%
2020	8	15.1%
2021	4	7.5%
2022	11	20.8%
2023	8	15.1%
2024	6	11.3%
2025partial year	7	13.2%

Which technologies does Route 92 Medical, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 52

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 49

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 25

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Route 92 Medical, Inc.'s patent record in context - here's where to go next.

Route 92 Medical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 98.1% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #6,379 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Route 92 Medical, Inc. against Purity (Xiamen) Sanitary Ware Co., Ltd, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.